Secukinumab treatment of hidradenitis suppurativa: questions remain – Authors' reply

Overall, confirmed and suspected SARS-CoV-2 infections and related adverse events were low, with no trends suggesting a predisposition to SARS-CoV-2 infection.1 The only case of COVID-19 pneumonia was reported in the placebo group of the SUNRISE trial (table S4 in Appendix 1). The authors concur tha...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Lancet (British edition) 2024-02, Vol.403 (10427), p.617-618
Hauptverfasser:	Kimball, Alexa B, Ravichandran, Shoba
Format:	Artikel
Sprache:	eng
Schlagworte:	Advisory committees COVID-19 COVID-19 vaccines Fistulae Infections Placebos Severe acute respiratory syndrome coronavirus 2 Statistical analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!